carbamates has been researched along with B16 Melanoma in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "flank injection of B16 melanoma cells." | 1.38 | The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action. ( Bouzin, C; Feron, O; Gallez, B; Hamtiaux, L; Lambert, DM; Masquelier, J; Muccioli, GG, 2012) |
| " It was discovered that long-term administration of 1." | 1.32 | [Cell differentiation in human melanoma cells caused by dicarbamine (ultrastructural investigation)]. ( Andronova, NV; Bryzgalov, IP; Nebol'sin, VE; Raĭkhlin, NT; Sedakova, LA; Smirnova, EA; Sorokina, IuD; Treshchalina, EM; Zheltukhina, GA, 2003) |
| " Pharmacokinetic studies in rats demonstrated that oral absorption of FB642 was variable and may be saturated at the 2000 mg/kg dose level since higher doses failed to produce a further increase in the area under the time concentration curve." | 1.31 | Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642). ( Camden, JB; Dexter, DL; Hao, D; Mangold, GL; Marty, J; Moore, RV; Rizzo, JD; Stringer, S; Von Hoff, DD; Weitman, SD, 2002) |
| "A higher cytotoxicity to B16 melanoma cells than to YAC-1 and to lymphocytes was demonstrated for the tyrosine containing nitrosoureas in comparison with CCNU." | 1.31 | Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents. ( Gadjeva, V, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deuker, MM | 1 |
| Marsh Durban, V | 1 |
| Phillips, WA | 1 |
| McMahon, M | 1 |
| Morikawa, T | 1 |
| Kitagawa, N | 1 |
| Tanabe, G | 1 |
| Ninomiya, K | 1 |
| Okugawa, S | 1 |
| Motai, C | 1 |
| Kamei, I | 1 |
| Yoshikawa, M | 1 |
| Lee, IJ | 1 |
| Muraoka, O | 1 |
| Hamtiaux, L | 1 |
| Masquelier, J | 1 |
| Muccioli, GG | 1 |
| Bouzin, C | 1 |
| Feron, O | 1 |
| Gallez, B | 1 |
| Lambert, DM | 1 |
| Hao, D | 1 |
| Rizzo, JD | 1 |
| Stringer, S | 1 |
| Moore, RV | 1 |
| Marty, J | 1 |
| Dexter, DL | 1 |
| Mangold, GL | 1 |
| Camden, JB | 2 |
| Von Hoff, DD | 2 |
| Weitman, SD | 1 |
| Raĭkhlin, NT | 1 |
| Nebol'sin, VE | 1 |
| Zheltukhina, GA | 1 |
| Bryzgalov, IP | 1 |
| Sorokina, IuD | 1 |
| Andronova, NV | 1 |
| Sedakova, LA | 1 |
| Smirnova, EA | 1 |
| Treshchalina, EM | 1 |
| Hammond, LA | 1 |
| Davidson, K | 1 |
| Lawrence, R | 1 |
| Weitman, S | 1 |
| Izbicka, E | 1 |
| Gadjeva, V | 1 |
| Anderson, WK | 1 |
| Bhattacharjee, D | 1 |
| Houston, DM | 1 |
8 other studies available for carbamates and B16 Melanoma
| Article | Year |
|---|---|
PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma.
Topics: Animals; Carbamates; Cell Line, Tumor; Cell Proliferation; Humans; MAP Kinase Kinase 1; MAP Kinase K | 2015 |
Quantitative Determination of Alkaloids in Lotus Flower (Flower Buds of Nelumbo nucifera) and Their Melanogenesis Inhibitory Activity.
Topics: Alkaloids; Animals; Carbamates; Cell Line, Tumor; Chromatography, Liquid; Enzyme Activation; Flowers | 2016 |
The association of N-palmitoylethanolamine with the FAAH inhibitor URB597 impairs melanoma growth through a supra-additive action.
Topics: Amides; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Modulators; Carbamates; Cell De | 2012 |
Preclinical antitumor activity and pharmacokinetics of methyl-2-benzimidazolecarbamate (FB642).
Topics: Animals; Antineoplastic Agents; Area Under Curve; Benzimidazoles; Carbamates; Cell Division; Cell Su | 2002 |
[Cell differentiation in human melanoma cells caused by dicarbamine (ultrastructural investigation)].
Topics: Animals; Antineoplastic Agents; Carbamates; Cell Differentiation; Humans; Immunohistochemistry; Mela | 2003 |
Exploring the mechanisms of action of FB642 at the cellular level.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Breast Neoplasms; Carbamates; Cell Cycle; | 2001 |
Structure-based design of nitrosoureas containing tyrosine derivatives as potential antimelanoma agents.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Carbamates; Cell Division; Drug Screening | 2002 |
Design, synthesis, antineoplastic activity, and chemical properties of bis(carbamate) derivatives of 4,5-bis(hydroxymethyl)imidazole.
Topics: Animals; Antineoplastic Agents; Carbamates; Chemical Phenomena; Chemistry; Drug Evaluation, Preclini | 1989 |